FDA 483 - Reading Hospital - July 30, 2025

An FDA inspection of Reading Hospital's blood bank identified significant deficiencies in its quality management system. The hospital failed to thoroughly investigate and document unexplained discrepancies related to blood product antigen testing errors and temperature control issues during transport. Additionally, the firm did not maintain adequate quality control records, specifically failing to investigate a blood storage refrigerator malfunction and complete required incident reports.